{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the progressive degeneration of dopaminergic neurons and the formation of Lewy bodies. Mutations in PARK2, encoding Parkin, are linked to autosomal recessive juvenile onset Parkinsonism. Parkin functions as a ubiquitin-protein ligase and is involved in mitochondrial dynamics and mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving Parkin in mitochondrial quality control and mitophagy, relevant to the functional assay described for the C289G variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used immunocytochemistry, confocal microscopy, and mitochondrial fractionation assays to assess Parkin's relocation to damaged mitochondria and its role in mitophagy.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used (cellular localization and mitochondrial dynamics) effectively models the disease pathogenesis related to Parkin's role in mitophagy.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study included controls with wild-type Parkin and other mutants (e.g., R42P), used multiple replicates, and performed statistical analyses.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and other mutants) and replicates were used, and statistical analyses were performed, indicating a valid assay setup.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used known pathogenic (C289G) and other mutants (R42P) as controls to assess Parkin's function in mitophagy.",
          "judgment": "Yes",
          "reasoning": "Variant controls, including known pathogenic mutants, were used, enhancing the assay's validity for assessing the C289G variant's impact.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The C289G variant failed to relocate to damaged mitochondria and induce mitophagy, unlike wild-type Parkin or the R42P mutant.",
          "judgment": "Yes",
          "reasoning": "The variant's failure to perform Parkin's normal function in mitophagy supports its pathogenic role, as it disrupts a critical disease-related pathway.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study quantified the incidence of cells with Parkin relocation to mitochondria and mitophagy, but did not calculate OddsPath.",
          "judgment": "No",
          "reasoning": "While statistical analyses were performed, OddsPath was not calculated, but the study's quantification of functional defects supports a pathogenic interpretation.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The C289G variant in PARK2 disrupts Parkin's normal function in mitophagy, a critical pathway in Parkinson's disease pathogenesis. The study's use of controls, replicates, and statistical analyses supports a moderate strength of pathogenic evidence (PS3_moderate) for this variant."
    }
  ]
}